![Suresh Mahabhashyam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suresh Mahabhashyam
Director Técnico/Científico/I+D en CORVUS PHARMACEUTICALS, INC. .
Perfil
Suresh Mahabhashyam is currently working as the Vice President-Clinical Development at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Medical Director at Alexion Pharmaceuticals, Inc. from 2012 to 2015 and as the Vice President-Safety & Risk Management at Infinity Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Mahabhashyam holds a graduate degree from the University of North Texas Health Science Center and a doctorate degree from Bangalore Medical College & Research Institute.
Cargos activos de Suresh Mahabhashyam
Empresas | Cargo | Inicio |
---|---|---|
CORVUS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2020 |
Antiguos cargos conocidos de Suresh Mahabhashyam.
Empresas | Cargo | Fin |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 |
ALEXION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2015 |
Formación de Suresh Mahabhashyam.
University of North Texas Health Science Center | Graduate Degree |
Bangalore Medical College & Research Institute | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CORVUS PHARMACEUTICALS, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Suresh Mahabhashyam